| |
- Drug name: Otarmeni (lunsotogene parvec-cwha) by Regeneron
- Approved April 23, 2026
- Treats OTOF gene mutation deafness (~50 US babies/year)
- Trial of 20 kids: 16 had hearing improvements at 5 months
- 5 of 12 followed for ≥11 months had hearing essentially restored to normal
- Effect lasted…
|
Click here to view the original article.